Literature DB >> 25454264

Consensus document of the Spanish Urological Association on the management of uncomplicated recurrent urinary tract infections.

L Prieto1, M Esteban2, J Salinas3, J M Adot4, S Arlandis5, L Peri6, J M Cozar7.   

Abstract

INTRODUCTION: The clinical manifestations of urinary infections, commonly mild and uncomplicated, have resulted in a generally empirical therapeutic decision-making process, which does not help fight resistances to antibacterial agents, thus causing a high rate of recurrence.
OBJECTIVE: This study seeks to reduce the clinical variability in the diagnosis and treatment of uncomplicated recurrent urinary tract infections (RUTIs). MATERIAL AND
METHOD: The consensus document was developed using a nominal group methodology, using scientific evidence on RUTIs extracted from a systematic (noncomprehensive) literature review, along with the expert judgment of specialists and their experience in clinical practice.
RESULTS: RUTIs are considered the manifestation of at least 3 episodes of uncomplicated infection, with a positive culture in the past 12 months, in addition to (for men) the absence of structural or functional abnormalities. We maintain that the treatment should be empiric when suspecting RUTIs (prior to obtaining a urine sample for culture) in those patients who have a high probability of recurrence, associated risk factors and/or urinary or general symptoms, such as fever and chills. Homogeneous criteria are recommended for the diagnosis and treatment in order to fight the increased rates of resistance that the microorganisms develop against antimicrobial agents.
CONCLUSION: Imprecision in the identification of the infection requires a search for agreements on homogenized criteria and decision algorithms that guide the management of these patients.
Copyright © 2014 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bacteriuria; Consenso; Consensus; Infección del tracto urinario; Managing disease; Manejo enfermedad; Recurrence; Recurrencia; Urinary tract infection

Mesh:

Substances:

Year:  2014        PMID: 25454264     DOI: 10.1016/j.acuro.2014.10.003

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  1 in total

1.  Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.

Authors:  Cristóbal Ramírez Sevilla; Esther Gómez Lanza; Juan Llopis Manzanera; Jose Antonio Romero Martín; Miguel Ángel Barranco Sanz
Journal:  BMC Infect Dis       Date:  2019-10-28       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.